p19 Arf Suppresses Growth, Progression, and Metastasis of Hras-Driven Carcinomas through p53-Dependent and -Independent Pathways
Karen S. Kelly‐Spratt(Fred Hutch Cancer Center), Christopher J. Kemp(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa)
Cited by 81
Related Papers
Targeting BET Proteins BRD2 and BRD3 in Combination with PI3K-AKT Inhibition as a Therapeutic Strategy for Ovarian Clear Cell Carcinoma
|Molecular Cancer Therapeutics|2021|30
Synergy between Prkdc and Trp53 regulates stem cell proliferation and GI-ARS after irradiation
|Cell Death and Differentiation|2017|25